Sarah Boyce, President and CEO: Avidity Biosciences RNA Sell · Filed 24/01/23

Trade details

Type: Insider sale
Amount: $51,581.96
Shares · price: 5,092 sh · $10.13 a share
Held after: 44,008 sh
Stock: Avidity Biosciences RNA
Person: Sarah BoycePresident and CEO
Trade date: 24/01/22
Filed: 24/01/23
Days to filing: 1 days

Sold 10.4% of holdings

Share of holding sold: 10.4%

Avidity Biosciences trades, last 26 weeks

What else happened in Avidity Biosciences around then

Filed or reported within 30 days of the trade day · 23/12/23~24/02/21

Sarah Boyce's recent trades

Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$579.1K
7,993 sh
$579.1K
Filed 01/23
Traded 01/21
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$463.2K
6,394 sh
$463.2K
Filed 01/23
Traded 01/21
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$619.4K
8,576 sh
$619.4K
Filed 01/09
Traded 01/07
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$2.5M
50,000 sh
$2.5M
Filed 25/09/05
Traded 25/09/05
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$1.2M
25,000 sh
$1.2M
Filed 25/08/29
Traded 25/08/28